Zydus Life shares gain 5% as Q3 results beat estimates; Revenue, EBITDA up around 30% each
Published on 09/02/2026 02:06 PM
Zydus Life shares gain 5% as Q3 results beat estimates; Revenue, EBITDA up around 30% eachZydus Life's third quarter results beat estimates across parameters.The company's revenue increased 30.3% to ₹6,865 crore from ₹5,269 crore in the third quarter of the previous fiscal. It was also above CNBC-TV18 poll's ₹6,294.3 crore.By Shloka Badkar February 9, 2026, 2:06:31 PM IST (Updated)1 Min Read(Photo Credit : CNBC-TV18 Library )Shares of Zydus Lifesciences gained over 4% on Monday, February 9, after the company reported its third quarter earnings.
Zydus Life's December quarter results beat estimates across parameters.
The company's net profit of ₹1,042 crore was higher than Street estimates of ₹940 crore. It was up 2% from the previous year's ₹1,023.5 crore.
The company's revenue increased 30.3% to ₹6,865 crore from ₹5,269 crore in the third quarter of the previous fiscal. It was also above CNBC-TV18 poll's ₹6,294.3 crore.
Zydus Life's earnings before interest, tax, depreciation and amortisation (EBITDA) increased 31% to ₹1,817 crore from ₹1,388 crore in the previous year. It was also higher than Street expectations of ₹1,516 crore.
Its margin expanded to 26.5% from 26.3% in the year-ago period and from CNBC-TV18 poll's 24%.
The company reported forex gain of ₹164 crore compared to ₹183 crore in the previous year.
Zydus Life shares gained 5% to hit an intraday high of ₹933.35 apiece on Monday. The stock was up 3.6% at ₹920.1 apiece around 1.35 pm. It has gained 2.9% in the past month.
Also Read: Textile stocks surge up to 8% as India-US interim trade framework lifts sentimentContinue ReadingFirst Published: Feb 9, 2026 1:43 PM ISTTagsshare market todayzydus lifeZydus Lifesciences